Tetra Gets NIH Award To Develop New Alzheimer's Drug
Tetra Discovery Partners LLC, a developer of new treatments for major neurological conditions based on PDE4 modulation in the brain, announced it has been awarded a five-year cooperative agreement by the National Institutes of Health. \
